Cited by 4,649Cancer-related Molecular PathwaysDevelopmental Biology and Gene RegulationCell death mechanisms and regulation

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Donehower, Lawrence A., Harvey, Michele, Slagle, Betty L., McArthur, Mark J., Montgomery, Charles A., Butel, Janet S., Bradley, Allan·1992·Nature

DOI 10.1038/356215a0

Open this paper in CoChat — free account

Abstract

Mutations in the p53 tumour-suppressor gene are the most frequently observed genetic lesions in human cancers. To investigate the role of the p53 gene in mammalian development and tumorigenesis, a null mutation was introduced into the gene by homologous recombination in murine embryonic stem cells. Mice homozygous for the null allele appear normal but are prone to the spontaneous development of a variety of neoplasms by 6 months of age. These observations indicate that a normal p53 gene is dispensable for embryonic development, that its absence predisposes the animal to neoplastic disease, and that an oncogenic mutant form of p53 is not obligatory for the genesis of many types of tumours.

Integrity signals

Registry

Crossref · 10.1038/356215a0

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
The p53 tumour suppressor gene
Levine, A. J., Momand, J. A., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,785
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
T antigen is bound to a host protein in SY40-transformed cells
Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456
Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
Soriano, P. M., Montgomery, C. A., Geske, R. S., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 1,997
Self-citation
The p53 proto-oncogene can act as a suppressor of transformation
Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987
Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Baker, S. J., Markowitz, S. D., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,742
Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: A general strategy for targeting mutations to non-selectable genes
Mansour, S. L., Thomas, K. R., & Capecchi, M. R. (1988) · Nature · doi:10.1038/336348a0 · Cited by 1,683

Flagged first, then by citations

Show all 48 references

Research works printed but not linked: 10

Mowat, M., Cheng, A., Kicumca, N., Bernstein, A. & Benchimol, S. Nature 61, 2777–2781 (1985).
Ben David, Y., Prideaux, V. R., Chow, V., Benchimol, S. & Bernstein, A. Oncogene 3, 179–185 (1988).
Stürzbecher, H.-W. et al. Oncogene 5, 795–801 (1990).
Shaulsky, G., Ben-Ze'ev, A. & Rotter, V. Oncogene 5, 1707–1711 (1990).
Soussi, T., de Fromentel, C. C. & May, P. Oncogene 5, 945–952 (1990).
Bradley, A. in Tetratocarcinomas and Embryonic Stem Cells: A Practical Approach (ed. Robertson, E. J.) 113–151 (IRL, Oxford, 1987).
Stutman, O. Fed. Proc. Fed. Am. Soc. exp. Biol. 33, 2028–2032 (1974).
Yandell, D. W. Proc. Am. Assoc. Cancer Res. 32, 459–460 (1991).
Sepulveda, A. R. et al. Cancer Res. 49, 6108–6117 (1989).
Slagle, B. L., Lanford, R. E., Medina, D. & Butel, J. S. Cancer Res. 42, 2155–2162 (1984).

Sorted by citations

Items 401–500 of 1,032

UV-induced signal transduction
Bender, K., Blattner, C., Knebel, A., Iordanov, M. S., Herrlich, P., & Rahmsdorf, H. J. (1997) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/s1011-1344(96)07459-3 · Cited by 268
InheritedTP53Mutations and the Li–Fraumeni SyndromePreprint
Guha, T., & Malkin, D. M. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026187 · Cited by 266
Declining p53 function in the aging process: A possible mechanism for the increased tumor incidence in older populations
Feng, Z., Hu, W., Teresky, A. K., Hernando, E., Cordon-Cardo, C., & Levine, A. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708043104 · Cited by 264
Cell Cycle Control, Checkpoint Mechanisms, and Genotoxic Stress
Shackelford, R. E., Kaufmann, W. K., & Paules, R. S. (1999) · Environmental Health Perspectives · doi:10.1289/ehp.99107s15 · Cited by 266
Role of Nicotinamide in DNA Damage, Mutagenesis, and DNA Repair
Surjana, D., Halliday, G. M., & Damian, D. L. (2010) · Journal of Nucleic Acids · doi:10.4061/2010/157591 · Cited by 264
Oncogenes and cell death
Harrington, E. A., Fanidi, A., & Evan, G. I. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90100-7 · Cited by 264
Identifying Chemical Carcinogens and Assessing Potential Risk in Short-Term Bioassays Using Transgenic Mouse Models
Tennant, R. W., French, J. E., & Spalding, J. W. (1995) · Environmental Health Perspectives · doi:10.1289/ehp.95103942 · Cited by 262
Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis
Humphreys, R. C., Krajewska, M., Krnacik, S., Jæger, R., Weiher, H., Krajewski, S., Reed, J. C., & Rosen, J. M. (1996) · Development · doi:10.1242/dev.122.12.4013 · Cited by 262
The p53 family: guardians of maternal reproduction
Levine, A. J., Tomasini, R., McKeon, F., Mak, T. W., & Melino, G. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3086 · Cited by 260
p53 transcriptional activity is essential for p53‐dependent apoptosis following DNA damage
Chao, C., Saito, S., Kang, J., Anderson, C. W., Appella, E., & Xu, Y. (2000) · The EMBO Journal · doi:10.1093/emboj/19.18.4967 · Cited by 260
MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer
Tisato, V., Voltan, R., Gonelli, A., Secchiero, P., & Zauli, G. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0500-5 · Cited by 259
The History of Tumor Virology
Javier, R. T., & Butel, J. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-3301 · Cited by 258
Self-citation
p53 Is Phosphorylated in Vitro and in Vivo by an Ultraviolet Radiation-induced Protein Kinase Characteristic of the c-Jun Kinase, JNK1
Milne, D., Campbell, L. E., Campbell, D. G., & Meek, D. W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5511 · Cited by 257
Expression of Mutant p53 Proteins Implicates a Lineage Relationship between Neural Stem Cells and Malignant Astrocytic Glioma in a Murine Model
Wang, Y., Yang, J., Zheng, H., Tomasek, G. J., Zhang, P., McKeever, P. E., Lee, E. Y.-H. P., & Zhu, Y. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.04.001 · Cited by 256
The meiotic checkpoint monitoring sypapsis eliminates spermatocytes via p53-independent apoptosis
Odorisio, T., Rodríguez, T. A., Evans, E. P., Clarke, A. R., & Burgoyne, P. S. (1998) · Nature Genetics · doi:10.1038/ng0398-257 · Cited by 256
Smoking, p53 Mutation, and Lung Cancer
Gibbons, D. L., Byers, L. A., & Kurie, J. M. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0539 · Cited by 255
Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system
Hughes, P. E., Alexi, T., Walton, M. R., Williams, C. E., Dragunow, M., CLARK, R. G., & Gluckman, P. D. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00057-4 · Cited by 255
Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer
Li, Y., Hively, W. P., & Varmus, H. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203273 · Cited by 254
p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling
Wang, X., Kua, H.-Y., Hu, Y., Guo, K., Zeng, Q., Wu, Q., Ng, H., Karsenty, G., Crombrugghe, B. D., Yeh, J. K., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200507106 · Cited by 254
Molecular genetics of osteosarcoma
Rickel, K., Fang, F., & Tao, J. (2016) · Bone · doi:10.1016/j.bone.2016.10.017 · Cited by 255
p53 Protein Exhibits 3′-to-5′ Exonuclease Activity
Mummenbrauer, T., Janus, F., Müller, B., Wiesmüller, L., Deppert, W., & Große, F. (1996) · Cell · doi:10.1016/s0092-8674(00)81309-4 · Cited by 253
Apoptosis in Human Disease: A New Skin for the Old Ceremony?
Fadeel, B., Orrenius, S., & Zhivotovsky, B. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1888 · Cited by 253
p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation.
Zhang, W., Grasso, L., McClain, C. D., Gambel, A. M., Cha, Y., Travali, S., Deisseroth, A., & Mercer, W. E. (1995) · PubMed · Cited by 253
Effects of genetic background on tumorigenesis in p53‐deficient mice
Donehower, L. A., Harvey, M., Vogel, H., McArthur, M. J., Montgomery, C. A., Park, S. H., Thompson, T., Ford, R. J., & Bradley, A. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940140105 · Cited by 252
Self-citation
The circadian clock in cancer development and therapy
Fu, L., & Kettner, N. M. (2013) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-396971-2.00009-9 · Cited by 251
Targeting Tumor Suppressor p53 for Cancer Therapy: Strategies, Challenges and Opportunities
Hong, B., van den Heuvel, A. P. J., Prabhu, V. V., Zhang, S., & El‐Deiry, W. S. (2014) · Current Drug Targets · doi:10.2174/1389450114666140106101412 · Cited by 251
A Novel Repressor, par-4, Modulates Transcription and Growth Suppression Functions of the Wilms’ Tumor Suppressor WT1
Johnstone, R. W., See, R. H., Sells, S. F., Wang, J., Muthukkumar, S., Englert, C., Haber, D. A., Licht, J. D., Sugrue, S. P., Roberts, T., et al. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.6945 · Cited by 251
Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach
Katz, J. P., Perreault, N., Goldstein, B. G., Actman, L., McNally, S. R., Silberg, D. G., Furth, E. E., & Kaestner, K. H. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.02.022 · Cited by 250
The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathways
Lu, X., Nguyen, T., Moon, S.-H., Darlington, Y. F., Sommer, M., & Donehower, L. A. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9127-x · Cited by 251
Self-citation
c-Myc and apoptosis
Packham, G., & Cleveland, J. L. (1995) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)00015-t · Cited by 250
The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging
Dumble, M. L., Moore, L. M., Chambers, S. M., Geiger, H., Zant, G. E. V., Goodell, M. A., & Donehower, L. A. (2006) · Blood · doi:10.1182/blood-2006-03-010413 · Cited by 249
Self-citation
The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.Preprint
Maheswaran, S., Englert, C., Bennett, P., Heinrich, G., & Haber, D. A. (1995) · Genes & Development · doi:10.1101/gad.9.17.2143 · Cited by 248
p53 is a suppressor of inflammatory response in mice
Komarova, E. A., Krivokrysenko, V. I., Wang, K., Neznanov, N., Chernov, M. V., Komarov, P. G., Brennan, M., Golovkina, T. V., Rokhlin, O. W., Kuprash, D. V., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3213fje · Cited by 247
A teratologic suppressor role for p53 in benzo(a)pyrene–treated transgenic p53-deficient mice
Nicol, C. J. B., Harrison, M. L., Laposa, R. R., Gimelshtein, I. L., & Wells, P. G. (1995) · Nature Genetics · doi:10.1038/ng0695-181 · Cited by 247
Apoptotic cell death in retinal degenerations
Remé, C. E., Grimm, C., Hafezi, F., Marti, A., & Wenzel, A. (1998) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(98)00009-3 · Cited by 246
Non-Stem Cell Origin for Oligodendroglioma
Persson, A. I., Petritsch, C. K., Swartling, F. J., Itsara, M., Sim, F. J., Auvergne, R. M., Goldenberg, D., VandenBerg, S. R., Nguyen, K. N., Yakovenko, S., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.033 · Cited by 246
Transcriptional role of p53 in interferon-mediated antiviral immunity
Muñoz‐Fontela, C., Macip, S., Martínez‐Sobrido, L., Brown, L. M., Ashour, J., García‐Sastre, A., Lee, S. W., & Aaronson, S. A. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080383 · Cited by 245
p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2Preprint
Urist, M. J., Tanaka, T., Poyurovsky, M. V., & Prives, C. L. (2004) · Genes & Development · doi:10.1101/gad.1221004 · Cited by 245
Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7.
Demers, G. W., Foster, S. A., Halbert, C. L., & Galloway, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4382 · Cited by 244
The Human Papillomavirus Type 16 E6 Gene Alone Is Sufficient To Induce Carcinomas in Transgenic Animals
Song, S., Pitot, H. C., & Lambert, P. F. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5887-5893.1999 · Cited by 244
KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer
Alam, H., Tang, M., Maitituoheti, M., Dhar, S. S., Kumar, M., Han, C. Y., Ambati, C. R., Amin, S. B., Gu, B., Chen, T.-Y., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.005 · Cited by 243
The role of the Bcl-2 protein family in cancer
Coultas, L., & Strasser, A. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00129-3 · Cited by 243
p53 in recombination and repair
Gatz, S. A., & Wiesmüller, L. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401903 · Cited by 242
Evidence for p53-Mediated Modulation of Neuronal Viability
Xiang, H., Hochman, D. W., Saya, H., Fujiwara, T., Schwartzkroin, P. A., & Morrison, R. S. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-21-06753.1996 · Cited by 242
An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control
Gualberto, A., Aldape, K., Kozakiewicz, K., & Tlsty, T. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5166 · Cited by 241
Gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53.
Hildesheim, J., Bulavin, D. V., Anver, M. R., Alvord, W. G., Hollander, M. C., Vardanian, L., & Fornace, A. J. (2002) · PubMed · Cited by 240
Uterine-specific p53 deficiency confers premature uterine senescence and promotes preterm birth in mice
Hirota, Y., Daikoku, T., Tranguch, S. L., Xie, H., Bradshaw, H. B., & Dey, S. K. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40051 · Cited by 238
TAp73 enhances the pentose phosphate pathway and supports cell proliferation
Du, W., Jiang, P., Mancuso, A., Stonestrom, A. J., Brewer, M. D., Minn, A. J., Mak, T. W., Wu, M., & Yang, X. (2013) · Nature Cell Biology · doi:10.1038/ncb2789 · Cited by 238
Mechanisms of switching on p53: a role for covalent modification?
Meek, D. W. (1999) · Oncogene · doi:10.1038/sj.onc.1202951 · Cited by 238
Ceramide and apoptosis
Kolesnick, R., & Hannun, Y. A. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01408-5 · Cited by 238
Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene‐mediated apoptosis.
Attardi, L. D., Lowe, S. W., Brugarolas, J., & Jacks, T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00739.x · Cited by 238
Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development.Preprint
Pan, H., & Griep, A. E. (1995) · Genes & Development · doi:10.1101/gad.9.17.2157 · Cited by 238
p53 alterations in human cancer: more questions than answers
Soussi, T. (2007) · Oncogene · doi:10.1038/sj.onc.1210280 · Cited by 236
Tumor suppressor p53 meets microRNAs
Feng, Z., Zhang, C., Wu, R., & Hu, W. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq040 · Cited by 238
Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53.
Lundgren, K., Montes de Oca Luna, R., McNeill, Y. B., Emerick, E. P., Spencer, B., Barfield, C. R., Lozano, G., Rosenberg, M. P., & Finlay, C. A. (1997) · Genes & Development · doi:10.1101/gad.11.6.714 · Cited by 235
Ku70
Li, G. C., Ouyang, H., Li, X., Nagasawa, H., Little, J. B., Chen, D. J., Ling, C., FUKS, Z. Y., & Cordon-Cardo, C. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80108-2 · Cited by 235
mdm2 Is Critical for Inhibition of p53 during Lymphopoiesis and the Response to Ionizing Irradiation
Mendrysa, S. M., McElwee, M. K., Michalowski, J., O'Leary, K. A., Young, K. M., & Perry, M. E. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.462-473.2003 · Cited by 234
Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease
Perier, C., Bové, J., Wu, D., Dehay, B., Choi, D., Jackson-Lewis, V. R., Rathke‐Hartlieb, S., Bouillet, P., Strasser, A., Schulz, J. B., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609874104 · Cited by 234
Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications
Gandhi, N. S., & Das, G. M. (2019) · Cells · doi:10.3390/cells8020089 · Cited by 237
THE GENETICS OF WILMS’ TUMOR—A Case of Disrupted Development
Hastie, N. D. (1994) · Annual Review of Genetics · doi:10.1146/annurev.ge.28.120194.002515 · Cited by 234
Lens fibre cell differentiation and organelle loss: many paths lead to clarity
Wride, M. A. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2010.0324 · Cited by 233
Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo
Midgley, C., Owens, B. M., Briscoe, C. V., Thomas, D. B., Lane, D. P., & Hall, P. A. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.5.1843 · Cited by 233
c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity
Stepniak, E., Ricci, R., Eferl, R., Sumara, G., Sumara, I., Rath, M., Hui, L., & Wagner, E. F. (2006) · Genes & Development · doi:10.1101/gad.390506 · Cited by 232
Aneuploidy, the somatic mutation that makes cancer a species of its own
DUESBERG, P. H., & Rasnick, D. (2000) · Cell Motility and the Cytoskeleton · doi:10.1002/1097-0169(200010)47:2 · Cited by 232
Deconstructing networks of p53-mediated tumor suppression in vivo
Kaiser, A. M., & Attardi, L. D. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.171 · Cited by 232
A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53–deficient mice
Harvey, M., Vogel, H. S., Morris, D. K., Bradley, A., Bernstein, A., & Donehower, L. A. (1995) · Nature Genetics · doi:10.1038/ng0395-305 · Cited by 232
Self-citation
Characterization of Transgenic Mice with Targeted Disruption of the Catalytic Domain of the Double-stranded RNA-dependent Protein Kinase, PKR
Abraham, N. B., Stojdl, D. F., Duncan, P. I., Méthot, N., Ishii, T. M., Dubé, M., Vanderhyden, B. C., Atkins, H. L., Gray, D. A., McBurney, M. W., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.5953 · Cited by 232
Anti-Apoptotic Effects of IGF-1 and PDGF on Human Intervertebral Disc Cells In Vitro
Gruber, H. E., Norton, H. J., & Hanley, E. N. (2000) · Spine · doi:10.1097/00007632-200009010-00002 · Cited by 231
The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth
Cadwell, C., & Zambetti, G. P. (2001) · Gene · doi:10.1016/s0378-1119(01)00696-5 · Cited by 231
Evidence for Replicative Repair of DNA Double-Strand Breaks Leading to Oncogenic Translocation and Gene Amplification
Difilippantonio, M. J., Petersen, S., Chen, H. T., Johnson, R., Jasin, M., Kanaar, R., Ried, T., & Nussenzweig, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020851 · Cited by 231
The construction of transgenic and gene knockout/knockin mouse models of human disease
Doyle, A. D., McGarry, M. P., Lee, N. A., & Lee, J. J. (2011) · Transgenic Research · doi:10.1007/s11248-011-9537-3 · Cited by 230
Transcriptional activation by p53 correlates with suppression of growth but not transformation
Crook, T. J. (1994) · Cell · doi:10.1016/0092-8674(94)90071-x · Cited by 229
An integrative view on sex differences in brain tumors
Sun, T., Plutynski, A., Ward, S., & Rubin, J. B. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1930-2 · Cited by 229
Molecular Pathogenesis of Rhabdomyosarcoma
Xia, S. J., Pressey, J. G., & Barr, F. G. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.51 · Cited by 227
Complex Transcriptional Effects of p63 Isoforms: Identification of Novel Activation and Repression Domains†
Ghioni, P., Bolognese, F., Duijf, P. H. G., van Bokhoven, H., Mantovani, R., & Guerrini, L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8659-8668.2002 · Cited by 227
atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity
Westphal, C. H., Rowan, S., Schmaltz, C., Elson, A., Fisher, D. E., & Leder, P. (1997) · Nature Genetics · doi:10.1038/ng0897-397 · Cited by 227
Spontaneous and genetically engineered animal models
Hansen, K., & Khanna, C. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.11.031 · Cited by 226
Procedural and Strain-related Variables Significantly Affect Outcome in a Murine Model of Focal Cerebral Ischemia
Connolly, E. S., Winfree, C. J., Stern, D. M., Stern, D. M., Solomon, R. A., & Pinsky, D. J. (1996) · Neurosurgery · doi:10.1097/00006123-199603000-00021 · Cited by 226
p53-family proteins and their regulators: hubs and spokes in tumor suppression
Collavin, L., Lunardi, A., & Sal, G. D. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.35 · Cited by 225
Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma.
Feitelson, M. A., & Duan, L. (1997) · Europe PMC (PubMed Central) · Cited by 225
Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53.Preprint
Bargonetti, J., Reynisdóttir, I., Friedman, P. N., & Prives, C. L. (1992) · Genes & Development · doi:10.1101/gad.6.10.1886 · Cited by 225
Conditional Loss of Uterine Pten Unfailingly and Rapidly Induces Endometrial Cancer in Mice
Daikoku, T., Hirota, Y., Tranguch, S. L., Joshi, A. R., DeMayo, F. J., Lydon, J. P., Ellenson, L. H., & Dey, S. K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1274 · Cited by 224
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
Zhu, H., Gao, H., Ji, Y., Zhou, Q., Du, Z., Tian, L., Jiang, Y., Yao, K., & Zhou, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01314-3 · Cited by 223
p53 and the pathogenesis of skin cancer
Benjamin, C. L., & Ananthaswamy, H. N. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.12.006 · Cited by 223
Apoptosis Triggered by Myc-Induced Suppression of Bcl-X L or Bcl-2 Is Bypassed during Lymphomagenesis
Eischen, C. M., Woo, D. D. L., Roussel, M. F., & Cleveland, J. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.15.5063-5070.2001 · Cited by 223
Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mousePreprint
Kalamarides, M., Niwa‐Kawakita, M., Leblois, H., Abramowski, V., Perricaudet, M., Janin, A., Thomas, G. D., Gutmann, D. H., & Giovannini, M. (2002) · Genes & Development · doi:10.1101/gad.226302 · Cited by 223
Tumour suppression by p53: the importance of apoptosis and cellular senescence
Zuckerman, V., Wolyniec, K., Sionov, R. V., Haupt, S., & Haupt, Y. (2009) · The Journal of Pathology · doi:10.1002/path.2584 · Cited by 222
The Cyclin-Dependent Kinase Inhibitor p21 WAF1 Is Required for Survival of Differentiating Neuroblastoma Cells
Poluha, W., Poluha, D. K., Chang, B. B., Crosbie, N. E., Schonhoff, C. M., Kilpatrick, D. L., & Ross, A. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1335 · Cited by 222
Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice
Bouvard, V., Zaitchouk, T., Vacher, M., Duthu, A., Canivet, M., Choisy, C., Nieruchalski, M., & May, E. (2000) · Oncogene · doi:10.1038/sj.onc.1203366 · Cited by 221
The role of the tumor suppressor p53 in spermatogenesis
Beumer, T. L., Roepers‐Gajadien, H. L., Gademan, I. S., van Buul, P. P. W., Gil‐Gómez, G., Rutgers, D. H., & de Rooij, D. G. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400396 · Cited by 221
Differential expression and regulation of chemokines JE, KC, and IP-10 gene in primary cultured murine hepatocytes
Wang, H., Gao, X., Fukumoto, S., Tademoto, S., Sato, K., & Hirai, K. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199911)181:2 · Cited by 45
Loss ofp53Induces Changes in the Behavior of Subventricular Zone Cells: Implication for the Genesis of Glial Tumors
Gil‐Perotín, S., Marin‐Husstege, M., Li, J., Soriano‐Navarro, M., Zindy, F., Roussel, M. F., García‐Verdugo, J. M., & Casaccia-Bonnefil, P. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3970-05.2006 · Cited by 220
Methylation of p53 by Set7/9 Mediates p53 Acetylation and Activity In Vivo
Kurash, J. K., Lei, H., Shen, Q. “., Marston, W. L., Granda, B. W., Fan, H. X., Wall, D., Li, E., & Gaudet, F. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.12.025 · Cited by 219
In vivo gene therapy with p53 or p21 adenovirus for prostate cancer.
Ja, E., Hall, S. J., Sehgal, I., Wang, J., Timme, T. L., Yang, G., Connell‐Crowley, L., Elledge, S. J., Ww, Z., & Harper, J. W. (1995) · PubMed · Cited by 219
Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes
Campisi, J. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00152-3 · Cited by 218
The role of SMARCB1/INI1 in the development of rhabdoid tumors
Roberts, C. W. M., & Biegel, J. A. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.5.8019 · Cited by 218
Proliferative inhibition, cell-cycle dysregulation, and induction of apoptosis by ursolic acid in human non-small cell lung cancer A549 cells
Hsu, Y., Kuo, P., & Lin, C. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.04.027 · Cited by 218
The role of p53 and pRB in apoptosis and cancer
Hickman, E. S. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00265-9 · Cited by 218
The p53 Tumor-Suppressor Gene
Levine, A. J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262008 · Cited by 218
Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice
Berrigan, D. A. (2002) · Carcinogenesis · doi:10.1093/carcin/23.5.817 · Cited by 216

Authors: Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A.
Affiliations: Baylor College of Medicine (US)
ORCID: Slagle, Betty L.
Butel, Janet S.
Bradley, Allan
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1992-03
Volume: 356
Issue: 6366
Pages: 215-221
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/356215a0
OpenAlex: W2126679757
Cited by: 4,649
References: 48
Citations by year: 2026: 16 · 2025: 48 · 2024: 51 · 2023: 74 · 2022: 76 · 2021: 80 · 2020: 86 · 2019: 92 · 2018: 84 · 2017: 96 · 2016: 119 · 2015: 89 · 2014: 121 · 2013: 146 · 2012: 157
FWCI: 82.13
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords: p53, tumor suppressor, spontaneous tumors, carcinogenesis, embryonic development, mouse model, neoplasms
MeSH terms: Alleles, Animals, Base Sequence, Blastocyst, DNA, Exons, Female, Genetic Vectors, Heterozygote, Homozygote, Male, Mice, Inbred CBA, Mice, Inbred C57BL, Mice, Transgenic, Molecular Sequence Data, Mutation, Neoplasms, Experimental, RNA, Messenger, Stem Cells, Blotting, Southern, Polymerase Chain Reaction, Genes, p53, Tumor Suppressor Protein p53, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks